Dialan, Ganiel A.

HRN: 19-58-87  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/28/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/28/2023
05/04/2023
IV
300mg
OD
UTI
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: